Risk of nephrogenic systemic fibrosis after exposure to newer gadolinium agents / Karen M. Goldstein [and nineteen others].

Author/creator Goldstein, Karen M. author.
Other author United States. Department of Veterans Affairs. Health Services Research and Development Service, issuing body.
Format Electronic
PublicationWashington, DC : U.S. Department of Veterans Affairs, Veterans Health Administration, Health Services Research & Development Service, 2019.
Description1 online resource (vi, 111 pages) : color illustrations.
Supplemental Contenthttps://purl.fdlp.gov/GPO/gpo146531
Subjects
Gadolinium compounds--Physiological effect. --United States.
Gadolinium compounds--Toxicology. --United States.
Skin--Fibrosis. --United States.
Organs (Anatomy)--Fibrosis. --United States.
Contrast-enhanced magnetic resonance imaging--United States.
Contrast media (Diagnostic imaging)--United States.
Chronic renal failure--Complications. --United States.

Running title Risk of NSF after exposure to newer GBCAs
SeriesEvidence synthesis program
Evidence-based synthesis program (Series) ^A1031189
General note"October 2019."
General noteGPO Cataloging Record Distribution Program (CRDP).
Bibliography noteIncludes bibliographical references.
Funding informationVA ESP 09-010
Source of descriptionDescription based on online resource; title from PDF cover (VA, viewed October 16, 2020).
GPO item number0985-A-12 (online)
Govt. docs number VA 1.107/3:N 35

Availability

Library Location Call Number Status Item Actions
Electronic Resources Access Content Online ✔ Available